Welcome to the Leukemia and Immuno-Oncology lab. The main focus of our lab is to explore the molecular mechanisms driving leukemia and lymphoma, and to develop novel therapeutic strategies specifically designed for these malignancies. In addition, our interest extends also to the study of autoimmune disorders, for which we aim to design and implement new targeted cell-based therapies.

Towards these goals, we use a broad range of experimental strategies that comprises basic molecular biology and biochemical methods, and bioinformatic analyses, as well as the use of in vitro and in vivo preclinical models, and experimental therapeutics techniques. These approaches allow us not only to address critical questions about the origin and progression of the diseases that we study but also to identify new therapeutic strategies for their treatment.